Estuardo Aguilar-Cordova

Chief Scientific Officer, Candel Therapeutics.

Companies

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

As of each latest filing. The line shows shares held over time.

Feb 21, 2025Returned to company 10,583 shares at $12.02 of Candel Therapeutics²
Feb 21, 2025Returned to company 10,582 shares at $12.02 of Candel Therapeutics²
Feb 10, 2025Returned to company 31,335 shares at $8.61 of Candel Therapeutics³
Dec 12, 2024Returned to company 200,000 shares at $10.04 of Candel Therapeutics⁴
Dec 12, 2024Returned to company 200,000 shares at $10.04 of Candel Therapeutics⁴
Dec 11, 2024Returned to company 200,000 shares at $8.53 of Candel Therapeutics⁴
Dec 11, 2024Returned to company 200,000 shares at $8.53 of Candel Therapeutics⁴
Oct 15, 2024Sold 10,412 shares at $6.03 of Candel Therapeutics⁵
Oct 14, 2024Sold 15,000 shares at $6.02 of Candel Therapeutics⁵
Oct 11, 2024Sold 15,000 shares at $6.05 of Candel Therapeutics⁵
Oct 3, 2024Sold 1,800 shares at $6.85 of Candel Therapeutics⁶
Oct 2, 2024Sold 26,988 shares at $6.92 of Candel Therapeutics⁶
Oct 1, 2024Sold 6,214 shares at $7.01 of Candel Therapeutics⁶
May 6, 2022Shares withheld for tax 54,074 shares at $3.65 of Candel Therapeutics⁷
May 6, 2022Exercised options 135,183 shares at $1.46 of Candel Therapeutics⁷

The numbers on this page point here. Each one links to the record it came from.